Psychoneuroimmunology is a field that investigates the interactions between the brain and the immune system. One important goal of this field of research is to translate basic research in order to understand how behavior affects health and resistance to disease in humans. This review evaluates the impact of depression on morbidity and mortality risk and asks whether neuroimmune mechanisms contribute to this association. Examples are drawn from three diseases: cardiovascular disease, infectious disease, and rheumatoid arthritis. Finally, the potential for biobehavioral interventions to impact psychological adaptation and the course of immune related disease is discussed.
INTRODUCTION
I am deeply honored and yet also humbled to write this 2001 Presidential Address for the Psychoneuroimmunology Research Society. Psychoneuroimmunology is a field that investigates the interactions between the brain and the immune system as a way of understanding how behavior affects health and resistance to disease. Thus, an important goal of psychoneuroimmunology and its Society is to conduct basic research that can be translated into clinically relevant health applications. For this address, I focus on the psychoneuroimmunology of depression, which has matured from a description of collective immune alterations found in depression to a challenging inquiry that is concerned with the clinical importance of immune abnormalities in depression.
Psychological stress and depressive symptoms are hypothesized to result in increased rates of morbidity and mortality particularly in patients with cardiovascular disease (Barefoot, Brummett, Helms, Mark, Siegler, & Williams, 2000; Covinsky, Kahana, Chin, Palmer, Fortinsky, & Landefeld, 1999 ; Jiang, Alexander, Christopher, Kuchibhatla, Gaulden, Cuffe, Blazing, Davenport, Califf, Krishnan, & O'Connor, 2001; Wulsin, Vaillant, & Wells, 1999) . However, less is known about the effects of major depression on the outcomes of other diseases and whether depression alters the onset and progression of chronic medical disorders such as infectious disease and/or inflammatory disorders. A further question concerns the mechanisms that account for the relationships between depression and the progression of immune-related disorders. The potential role of neuroimmune processes in mediating increases in disease risk in depressed populations has begun to be addressed by evaluating the effects of depression and depressive symptoms on specific immune measures and/ or immune markers of disease severity. If it is substantiated that biobehavioral factors impact immune related diseases, then it is equally important to know whether inter-
